Review: could Erbitux cause White blood cell count decreased?
Summary: White blood cell count decreased is found among people who take Erbitux, especially for people who are male, 60+ old, have been taking the drug for < 1 month, also take medication Cisplatin, and have Lung cancer - non-small cell.
We study 8,254 people who have side effects while taking Erbitux from FDA and social media. Among them, 194 have White blood cell count decreased. Find out below who they are, when they have White blood cell count decreased and more.
You are not alone: join a mobile support group for people who take Erbitux and have White blood cell count decreased >>>
Erbitux has active ingredients of cetuximab. It is often used in cancer. (latest outcomes from 8,273 Erbitux users)
White blood cell count decreased
White blood cell count decreased has been reported by people with hepatitis c, schizophrenia, multiple myeloma, multiple sclerosis, rheumatoid arthritis. (latest reports from 35,331 White blood cell count decreased patients)
On Feb, 22, 2015: 8,254 people reported to have side effects when taking Erbitux. Among them, 194 people (2.35%) have White Blood Cell Count Decreased.
Time on Erbitux when people have White blood cell count decreased * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|White blood cell count decreased||81.13%||18.87%||0.00%||0.00%||0.00%||0.00%||0.00% |
Gender of people who have White blood cell count decreased when taking Erbitux * :
|White blood cell count decreased||28.08%||71.92% |
Age of people who have White blood cell count decreased when taking Erbitux * :
|White blood cell count decreased||0.00%||1.03%||0.52%||0.00%||0.52%||3.61%||21.13%||73.20% |
Top conditions involved for these people * :
- Non-small cell lung cancer (28 people, 14.43%)
- Head and neck cancer (18 people, 9.28%)
- Rectal cancer (15 people, 7.73%)
- Gastric cancer (14 people, 7.22%)
- Oesophageal adenocarcinoma (13 people, 6.70%)
Top co-used drugs for these people * :
- Cisplatin (89 people, 45.88%)
- Taxol (63 people, 32.47%)
- Carboplatin (52 people, 26.80%)
- Radiation therapy (43 people, 22.16%)
- Decadron (25 people, 12.89%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have White Blood Cell Count Decreased while taking Erbitux?
You are not alone! Join a mobile support group:
- support group for people who take Erbitux and have White Blood Cell Count Decreased
- support group for people who take Erbitux
- support group for people who have White Blood Cell Count Decreased
Drugs in real world that are associated with:
Could your condition cause:
- A study of side effects of Erbitux for a 62-year old man with Ca Of Larynx. The patient has Anaphalaxsis
- A study of drug interactions between Wellbutrin Xl, Lexapro for a 29-year old woman with Depression. The patient has White Blood Cell Count Decreased
- A study of drug interactions between Plaquenil, Adderall Xr 25 for a 34-year old woman with Autoimmune Disorder, Add. The patient has Bone Pain, Monocyte Count Increased, White Blood Cell Count Decreased
- A study of drug interactions between Heparin, Insulin, Doxycycline, Gemcitabine, Erbitux, Abraxane for a 57-year old man with Dvt, Diabetes, Rash Generalised, Pancreatic Carcinoma Metastatic. The patient has Breathing Sounds - Abnormal (stridor), Breathlessness
- A study of drug interactions between Fluorouracil, Epirubicin Hydrochloride, Cyclophosphamide, Palonosetron Hydrochloride, Dexamethasone, Clonazepam, Alprazolam, Escitalopram for a 40-year old woman with Cancer - Breast, Panic Attack. The patient has Atypical-lympho And Monocyte Increased, Neutropenia, White Blood Cell Count Decreased
Recent Erbitux related drug comparison:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.